Intended and Unintended Consequences of Nonpayment for Preventable Complications

不支付可预防并发症的有意和无意的后果

基本信息

  • 批准号:
    8299934
  • 负责人:
  • 金额:
    $ 48.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Financial incentives, such as pay-for-performance (P4P) programs, are increasingly being used to improve physician behavior. However, the impact of these programs on improving quality of care for patients have been mixed, with some studies showing modest gains and others reporting little to no improvement on quality of care measures. Furthermore, unintended consequences of P4P programs have been demonstrated, including larger financial rewards for those hospitals with higher performance at baseline and significant financial losses for hospitals that serve large minority populations. As of October 1, 2008, Medicare implemented the use of a new financial mechanism-nonpayment for preventable complications (NPCC)-which is a "stick" rather than a "carrot". Medicare no longer pays hospitals for treating certain healthcare-associated infections (HAIs) that arise in patients if they are not present on admission. Our proposed research is unique and timely. There are no evaluations of the impact of NPPC, which is being implemented by one of the largest payers in the U.S. Despite lack of evidence for its efficacy, it is hoped that financial disincentives will motivate hospitals and providers to focus their efforts on reducing HAIs. While the goal is certainly worthy, the mechanism being used to motivate change should be rigorously evaluated to ensure that it achieves its intended consequence without the occurrence of unintended consequences. Our research seeks to understand the impact, both positive and negative, of NPPC on health outcomes and costs. We will assess the impact of Medicare's use of NPPC on outcomes and costs in hospitals that report data to Medicare and the National Healthcare Safety Network (NHSN). Our aims are: (1) To evaluate the impact of NPPC on HAI rates reported by Medicare (i.e. "billing" rates); (2) To evaluate the impact of NPPC on HAI rates reported by NHSN (i.e. "true" infection rates); (3) To explore whether NPPC reduces both "billing" and "true" infection rates in different types of hospitals (e.g. for-profit vs. not-for-profit) (4) To assess whether reduced reimbursement for HAIs as a result of NPPC disproportionately affects hospitals that care for a high proportion of poor or minority patients.
项目总结/摘要 财务激励措施,如按业绩付费(P4P)计划, 越来越多地被用于改善医生的行为。然而,这些影响 关于提高病人护理质量的项目好坏参半, 显示出适度的进步,其他人则报告护理质量几乎没有改善 措施此外,P4P计划的意外后果已经被 证明,包括更大的财政奖励那些医院, 为大型医院提供服务的医院的基线绩效和重大财务损失 少数民族人口。自2008年10月1日起,Medicare实施了新的 金融机制-可预防并发症不付款(NPCC)-这是一个 “大棒”,而不是“胡萝卜”。医疗保险不再支付医院治疗某些 如果患者不存在医疗保健相关感染(HAI),则会在患者中出现 入院 我们提出的研究是独特和及时的。没有对 NPPC的影响,这是由美国最大的支付者之一实施的。 尽管缺乏证据证明其有效性,但人们希望财政抑制措施将 激励医院和供应商集中精力减少HAI。虽然目标 当然是值得的,用于激励变革的机制应该严格 评估以确保其达到预期结果,而不会发生 意想不到的后果。我们的研究旨在了解影响,无论是积极的 NPPC对健康结果和成本的影响为负。 我们将评估医疗保险使用NPPC对结果和成本的影响, 向Medicare和国家医疗安全网络报告数据的医院 (NHSN)。我们的目的是:(1)评估NPPC对HAI率的影响, 医疗保险(即“账单”费率);(2)评估NPPC对报告的HAI费率的影响 (即“真实”感染率);(3)探讨NPPC是否减少了“账单” 不同类型医院的“真实”感染率(例如,营利性与非营利性)(4) 评估HAI的报销是否因NPPC而减少 不成比例地影响到照顾大部分穷人或少数民族的医院 患者

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Grace M Lee其他文献

Cultural Industries
文化产业
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Andrew G Wu;Gowri Madhavan;Kathy Deakins;Dana Evans;Angela Hayward;Caitlin Pugh;Angela Carter Stutts;Laurie Mustin;Katherine C. Staubach;Patricia Sisson;Maitreya Coffey;Anne Lyren;Grace M Lee;Sameer Gupta;Lucy Pereira;Gregory P. Priebe
  • 通讯作者:
    Gregory P. Priebe
Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonality
2005 年美国大型管理式医疗机构中青少年对脑膜炎球菌结合疫苗的使用情况:需求、供应和季节性
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    S. Lorick;Daniel Fishbein;Eric Weintraub;Pascale M Wortley;Grace M Lee;Fangjun Zhou;Robert Davis
  • 通讯作者:
    Robert Davis
Red Cell Exchange Decreases Sickle RBC-Induced Release of MPO from Neutrophils
  • DOI:
    10.1182/blood-2024-207819
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Y-Nhi Bui;Kimberly Boyle;Milena Batchvarova;Martha Delahunty;Marilyn J. Telen;Grace M Lee
  • 通讯作者:
    Grace M Lee
Complement Activation As a Biomarker for Platelet Activating Antibodies in Heparin-Induced Thrombocytopenia (HIT)
  • DOI:
    10.1182/blood-2024-208062
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Sooho S Myoung;Samuel Francis;Jonah Chen;Grace M Lee;Lubica Rauova;Mortimer Poncz;Douglas B. Cines;Maragatha Kuchibhatla;Sanjay Khandelwal;Gow Arepally
  • 通讯作者:
    Gow Arepally

Grace M Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Grace M Lee', 18)}}的其他基金

Defining and Preventing Ventilator-Associated Complications in Pediatrics
儿科呼吸机相关并发症的定义和预防
  • 批准号:
    8642155
  • 财政年份:
    2013
  • 资助金额:
    $ 48.87万
  • 项目类别:
Defining and Preventing Ventilator-Associated Complications in Pediatrics
儿科呼吸机相关并发症的定义和预防
  • 批准号:
    8414054
  • 财政年份:
    2013
  • 资助金额:
    $ 48.87万
  • 项目类别:
Defining and Preventing Ventilator-Associated Complications in Pediatrics
儿科呼吸机相关并发症的定义和预防
  • 批准号:
    8796722
  • 财政年份:
    2013
  • 资助金额:
    $ 48.87万
  • 项目类别:
Nonpayment for Preventable Complications: Impact on Hospital Practices and Health
可预防并发症不付款:对医院实践和健康的影响
  • 批准号:
    7701367
  • 财政年份:
    2009
  • 资助金额:
    $ 48.87万
  • 项目类别:
Preventing Avoidable Infectious Complications by Adjusting Payment (PAICAP)II
通过调整付款方式预防可避免的感染性并发症 (PAICAP)II
  • 批准号:
    8813055
  • 财政年份:
    2009
  • 资助金额:
    $ 48.87万
  • 项目类别:
Intended and Unintended Consequences of Nonpayment for Preventable Complications
不支付可预防并发症的有意和无意的后果
  • 批准号:
    8508789
  • 财政年份:
    2009
  • 资助金额:
    $ 48.87万
  • 项目类别:
Nonpayment for Preventable Complications: Impact on Hospital Practices and Health
可预防并发症不付款:对医院实践和健康的影响
  • 批准号:
    7897759
  • 财政年份:
    2009
  • 资助金额:
    $ 48.87万
  • 项目类别:
Intended and Unintended Consequences of Nonpayment for Preventable Complications
不支付可预防并发症的有意和无意的后果
  • 批准号:
    7785306
  • 财政年份:
    2009
  • 资助金额:
    $ 48.87万
  • 项目类别:
Intended and Unintended Consequences of Nonpayment for Preventable Complications
不支付可预防并发症的有意和无意的后果
  • 批准号:
    8111673
  • 财政年份:
    2009
  • 资助金额:
    $ 48.87万
  • 项目类别:
Intended and Unintended Consequences of Nonpayment for Preventable Complications
不支付可预防并发症的有意和无意的后果
  • 批准号:
    7937707
  • 财政年份:
    2009
  • 资助金额:
    $ 48.87万
  • 项目类别:

相似海外基金

Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响
  • 批准号:
    BB/Y003861/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Research Grant
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome.
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响。
  • 批准号:
    BB/Y004108/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Research Grant
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome.
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响。
  • 批准号:
    BB/Y003918/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Research Grant
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome.
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响。
  • 批准号:
    BB/Y004086/1
  • 财政年份:
    2024
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Research Grant
Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing
阿片类药物治疗癌症患者的疼痛:针对阿片类药物处方的国家政策的有意和无意的后果
  • 批准号:
    10707114
  • 财政年份:
    2022
  • 资助金额:
    $ 48.87万
  • 项目类别:
Intended and Unintended Consequences of the Merit-Based Incentive Payments System Program: Early Evidence
绩效激励支付系统计划的预期和非预期后果:早期证据
  • 批准号:
    10373483
  • 财政年份:
    2022
  • 资助金额:
    $ 48.87万
  • 项目类别:
Opioid Treatment of Pain in People with Cancer: Intended and unintended consequences of state policies addressing opioid prescribing
阿片类药物治疗癌症患者的疼痛:针对阿片类药物处方的国家政策的有意和无意的后果
  • 批准号:
    10523193
  • 财政年份:
    2022
  • 资助金额:
    $ 48.87万
  • 项目类别:
Evaluating the intended and unintended consequences of opioid prescribing interventions on primary care
评估阿片类药物处方干预措施对初级保健的预期和非预期后果
  • 批准号:
    443700
  • 财政年份:
    2021
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Operating Grants
DATADRIVEN: Data-driven campaigns: intended and unintended consequences for democracy
数据驱动:数据驱动的运动:对民主的有意和无意的后果
  • 批准号:
    ES/XX00052/1
  • 财政年份:
    2020
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Research Grant
Evaluating population-level medicine policy interventions: generating high-quality evidence about intended and unintended consequences
评估人口层面的医学政策干预措施:生成关于预期和非预期后果的高质量证据
  • 批准号:
    nhmrc : GNT1158763
  • 财政年份:
    2019
  • 资助金额:
    $ 48.87万
  • 项目类别:
    Early Career Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了